By the Vaccine Research and Development Center (ERAGEM) and Good Clinical Practice and Research Center (IKUM) within Kayseri Erciyes University (ERÜ). corona virusCovid-19 developed against the Turkish Ministry of Health and supported by the Turkish Health Institutes (TÜSEB) domestic vaccinePhase 1 study of the class was conducted on 44 volunteers.
Phase-2 study of the inactive vaccine started on 250 volunteers on 10 February and was completed on 9 March. The reporting process of the results obtained in the Phase-2 study has been completed.
THE MINISTRY OF HEALTH TO ANNOUNCED THE RESULTS
Results of the reports obtained Ministry of HealthIt was delivered to. It was learned that the results of the reported data will be announced by the Ministry of Health. Then, it was stated that Phase-3 phase will be started.
ERÜ Rector Prof. Dr. Mustafa Çalış said, “Our phase-2 study in domestic vaccine is finished. Fortunately, we achieved very good results. We have stated and reported that we will report to our Ministry of Health as of the end of April. We have achieved very good results. Our domestic vaccine study is a study we conducted with the support of the Ministry of Health and TUSEB. Phase-3 studies have also started under the coordination of the Ministry of Health and TUSEB. I hope Phase-3 studies will be completed as soon as possible and we will have our local vaccine as soon as possible ”.
“WE ACHIEVED BETTER RESULTS THAN WE EXPECTED”
“As a result of the phase-3 studies, many rates such as hospitalization rate and sickness rate will be examined after dosing,” said Çalış, “Phase-1 studies are mostly studies related to side effects. There were no serious side effects there and then we switched to phase-2 study. Effectiveness was looked at in Phase-1, but it was very important in terms of actual side effects and safety. Phase-2 phase was more important than the activity phase. In Phase-2, we achieved much better results than we expected. We were very proud and it made us very happy. We have reported this to the Ministry of Health. As a result of phase-3 studies, many rates such as hospitalization rate and sickness rate will be examined after dosing. Then, hopefully, we hope that the phase-3 study will be successful in a short time and we will switch to our local vaccine as soon as possible ”.
Download the NTV application, be informed about the developments
“DON’T BELIEVE THE VACCINE LEGENDS”